Skip to Content
You are currently on the new version of our website. Access the old version .
AntioxidantsAntioxidants
  • Review
  • Open Access

1 April 2021

26 Pages

Complexity of the Nano-Bio Interface and the Tortuous Path of Metal Oxides in Biological Systems

and
1
Department of Biology, St. Lawrence University, Canton, NY 13617, USA
2
White River Junction VA Medical Center, White River Junction, VT 05009, USA
*
Author to whom correspondence should be addressed.

Abstract

Metal oxide nanoparticles (NPs) have received a great deal of attention as potential theranostic agents. Despite extensive work on a wide variety of metal oxide NPs, few chemically active metal oxide NPs have received Food and Drug Administration (FDA) clearance. The clinical translation of metal oxide NP activity, which often looks so promising in preclinical studies, has not progressed as rapidly as one might expect. The lack of FDA approval for metal oxide NPs appears to be a consequence of the complex transformation of NP chemistry as any given NP passes through multiple extra- and intracellular environments and interacts with a variety of proteins and transport processes that may degrade or transform the chemical properties of the metal oxide NP. Moreover, the translational models frequently used to study these materials do not represent the final therapeutic environment well, and studies in reduced preparations have, all too frequently, predicted fundamentally different physico-chemical properties from the biological activity observed in intact organisms. Understanding the evolving pharmacology of metal oxide NPs as they interact with biological systems is critical to establish translational test systems that effectively predict future theranostic activity.

Article Metrics

Citations

Article Access Statistics

Multiple requests from the same IP address are counted as one view.